Desirudin indications and usage

Revision as of 01:18, 3 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Desirudin}} {{CMG}}; {{AE}} {{SS}} ==Indications and Usage== Iprivask is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Desirudin
IPRIVASK® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Indications and Usage

Iprivask is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in patients undergoing elective hip replacement surgery.[1]


References

  1. ↑ "IPRIVASK (DESIRUDIN) KIT [MARATHON PHARMACEUTICALS, LLC]". Retrieved 3 February 2014.

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Desirudin_indications_and_usage&oldid=937249"